WOMBAT: World of Molecular Bioactivity

Chemoinformatics in Drug Discovery

Volumn 23, Issue , 2005, Pages 221-239

  Olah, Marius ^a   Mracec, Maria ^b   Ostopovici, Liliana ^b   Rad, Ramona ^b   Bora, Alina ^b   Hadaruga, Nicoleta ^b   Olah, Ionela ^b   Banda, Magdalena ^b   Simon, Zeno ^b   Mracec, Mircea ^b   Oprea, Tudor I ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b ACADEMY OF ROMANIAN SCIENTISTS   (Romania)

Author keywords

Databases; Libraries; WOMBAT (world of molecular bioactivity)

Indexed keywords

DATABASE SYSTEMS; LIBRARIES;

DATABASE STRUCTURES; FUTURE CHALLENGES; LITERATURE DATA; WOMBAT (WORLD OF MOLECULAR BIOACTIVITY);

DATA MINING;

EID: 84968923096     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603743.ch9     Document Type: Chapter

References (44)

1. Chemical Abstracts online and its search module, SciFinder, are available from the American Chemical Society, http://www.cas.org/SCIFINDER/ 2004.
2. The Beilstein Information Systems is available from http://www.beilstein.com/.
3. The Spresi Database is available from InfoChem GmbH, München, http://www.spresiweb.de/andfromDaylightChemical Information Systems, http://www.daylight.com/products/databases/Spresi.html.
4. MDDR is available from MDL Information Systems, http://www.mdli.com/products/finders/databasefinder/andfromProusSciencePublishers,http://www.prous.com/index.html.
5. WDI, the Derwent World Drug Index, is available from Derwent Publications Ltd., http://thomsonderwent.com/products/lr/wdi/andfromDaylightChemicalInformation Systems,http://www.daylight.com/products/databases/WDI.html.
6. The Current Patents Fast Alert database is available from Current Patents Ltd., London, UK, http://www.current-patents.com/.
7. The Comprehensive Medicinal Chemistry database is available from MDL Information Systems, Inc., http://www.mdli.com/products/knowledge/medicinalchem/index.jsp.
8. The Physician Desk Reference is produced by Thomson Healthcare, 2003, ISBN 1-56363-472-4, and is available online at http://www.pdr.net/.
9. SAVCHUK, N.P., BALAKIN, K.V., and TKACHENKO, S.E. Exploring the chemogenomic knowledge space with annotated chemical libraries. Curr. Opin. Chem. Biol. 2004, 8, 412-417.
10. WOMBAT 2004. 1 is available from Sunset Molecular Discovery, Santa Fe, NM, http://www.sunsetmolecular.com from Metaphorics LLC, Santa Fe, NM, New Mexico, http://www.metaphorics.com/.
11. WEININGER, D. SMILES 1. Introduction and encoding rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31-36.
12. WEININGER, D., WEININGER, A., and WEININGER, J.L. SMILES 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci. 1989, 29, 97-101.
13. The Enzyme Nomenclature is recommended by the International Union of Biochemistry and Molecular Biology, and is available at http://www.chem.qmul.ac.uk/iubmb/enzyme/.
14. The Digital Object Identifier (DOI) is a system for identifying and exchanging intellectual property in the digital environment (http://www.doi.org/). An object is directly accessible using the customized address http://dx.doi.org/DOI VALUE.
15. Swiss-Prot Protein knowledgebase database, http://kr.expasy.org/sprot/.
16. LIPINSKI, C.A., LOMBARDO, F., DOMINY, B.W., and FEENEY, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
17. LEO, A. Estimating LogPoct from structures. Chem. Rev. 1993, 5, 1281-1306.
18. RAN, Y., JAIN, N., and YALKOWSKY, S.H. Prediction of aqueous solubility of organic compounds by the general solubility equation (GSE). J. Chem. Inf. Comput. Sci. 2001, 41, 1208-1217.
19. OPREA, T.I. Chemoinformatics in lead discovery. In Chemoinformatics in Drug Discovery, OPREA, T.I. (Ed.). Wiley-VCH, Weinheim, 2004, 25-41.
20. O'NEIL, M.J. Merck Index, 13th edition. Merck & Co. Inc, Rahway, NJ, 2001.
21. OPREA, T.I., OLAH, M., OSTOPOVICI, L., RAD, R., and MRACEC, M. On the propagation of errors in the QSAR literature. In EuroQSAR 2002 - Designing Drugs and Crop Protectants: Processes, Problems and Solutions, FORD, M., LIVINGSTONE, D., DEARDEN, J., and VAN DE WATERBEEMD, H. (Eds). Blackwell Publishing, New York, 2003, 314-315.
22. ACDName is available from Advanced Chemistry Development Inc., Toronto, Ontario, http://www.acdlabs.com/.
23. COATS, E.A. The CoMFA steroids as a benchmark dataset for development of 3D-QSAR methods. In 3D QSAR in Drug Design, Vol. 3, Recent Advances, KUBINYI, H., FOLKERS, G., and MARTIN, Y.C. (Eds). Kluwer/ESCOM, Dordrecht, Netherlands, 1998, 199-213.
24. CHEN, Q., WU, C., MAXWELL, D., KRUDY, G.A., DIXON, R.A.F., and YOU, T.J. A 3D-QSAR analysis of in vitro binding affinity and selectivity of 3-izoxazolylsulfonylaminothiophenes as endothelin receptor antagonists. Quant. Struct.-Act. Relat. 1999, 18, 124-133.
25. WU, C., CHAN, M.F., STAVROS, F., RAJU, B., OKUN, I., MONG, S., KELLER, K.M., BROCK, T., KOGAN, T.P., and DIXON, R.A.F. Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J. Med. Chem. 1997, 40, 1690-1697.
26. WU, C., CHAN, M.F., STAVROS, F., RAJU, B., OKUN, I., and CASTILLO, R.S. Structure-activity relationships of N2-aryl-3-(isoxazolylsulfamoyl)-2- thiophenecarboxamides as selective endothelin receptor-A antagonists. J. Med. Chem. 1997, 40, 1682-1689.
27. SO, S.S. and KARPLUS, M. Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications. J. Med. Chem. 1997, 40, 4360-4371.
28. BURKE, B.J. and HOPFINGER, A.J. 1-(Substituted-benzyl)imidazole-2(3H)thione inhibitors of dopamine β-hydroxylase. J. Med. Chem. 1990, 33, 274-281.
29. VEDANI, A., MCMASTERS, D.R., and DOBLER, M. Multi-conformational ligand representation in 4D-QSAR: Reducing the bias associated with ligand alignment. Quant. Struct.-Act. Relat. 2000, 19, 149-161.
30. BLOMMAERT, A.G.S., DHOTEL, H., DUCOS, B., DURIEUX, C., GOUDREAU, N., BADO, A., GARBAY, C., and ROQUES, B.P. Structurebased design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. J. Med. Chem. 1997, 40, 647-658.
31. OPREA, T.I., WALLER, C.L., and MARSHALL, G.R. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. II. Predictive power using limited exploration of alternate binding modes. J. Med. Chem. 1994, 37, 2206-2215.
32. LEO, A. Personal communication, 2004.
33. ABRAHAM, D. Burger's Medicinal Chemistry, 6th edition. Wiley-VCH, Weinheim, 2003.
34. ABRAHAM, D. Personal communication, 2004.
35. PARKER, E.M., GRISEL, D.A., IBEN, L.G., and SHAPIRO, R.S. A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-HT1B receptors. J. Neurochem. 1993, 60, 380-383.
36. HANN, M.M., LEACH, A., and GREEN, D.V.S. Computational chemistry, molecular complexity and screening set design. In Chemoinformatics in Drug Discovery, OPREA, T.I. (Ed.). Wiley-VCH, Weinheim, 2004, 43-57.
37. HANN, M.M. and OPREA, T.I. Pursuing the lead likeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 2004, 8, 255-263.
38. GOODNOW, R.A. Jr., GILLESPIE, P., and BLEICHER, K. Chemoinformatic tools for library design and the hit-to-lead process: A user's perspective. In Chemoinformatics in Drug Discovery, OPREA, T.I. (Ed.). Wiley-VCH, Weinheim, 2004, 381-435.
39. BARINGHAUS, K.H. and MATTER, H. Efficient strategies for lead optimization by simultaneously addressing affinity, selectivity and pharmacokinetic parameters. In Chemoinformatics in Drug Discovery, OPREA, T.I. (Ed.). Wiley-VCH, Weinheim, 2004, 333-379.
40. CONGREVE, M., CARR, R., MURRAY, C., and JHOTI, H.A. 'Rule of Three' for fragment-based lead discovery? Drug Disc. Today 2003, 8, 876-877.
41. POVOLNA, V., DIXON, S., and WEININGER, D. CABINET - chemistry and biological informatics network. In Chemoinformatics in Drug Discovery, OPREA, T.I. (Ed.). Wiley-VCH, Weinheim, 2004, 241-269.
42. CABINET is available from Metaphorics LLC, Santa Fe, NM, http://cabinet.metaphorics.com/.
43. HANSCH, C., HOEKMAN, D., LEO, A., WEININGER, D., and SELASSIE, C.D. C-QSAR database. Available from the BioByte Corporation, Claremont, CA, http://www.biobyte.com/.
44. FURET, P., GAY, B., CARAVATTI, G., GARCIA-ECHEVERRIA, C., RAHUEL, J., SCHOEPFER, J., and FRETZ, H. Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain. J. Med. Chem. 1998, 41, 3442-3449.